George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Buying RF out? What Bullsh$$t you are talking. Leave us PI's alone.
Sareum has willingly chosen RF as partners and supposed Rf is taken over any contract remains valid right to the end. Preparing the ground for another (WARP) investing ground like SOG already did?
Go home Modell and the like . You re alone with your thoughts.
Refer to the report FY2023 and H1 2024.
As a matter of fact we stated approx 3,2 M GBP loss for the year ended and given the excessive research re 1802 the current year we accumulated already 2/3 loss end of December 2023 at half years time.
Why the need and rush to waste the money tripple time? By the time we get the MAD results were are ready for a takeover that will compensate warrants more or less only but provide advanced research and compounds to the suiter.
I hope the BODhas a plan, even when it is that bad.
Pharmas and financiers just a different form of criminal.
Nice statement I like and still am questioning the BODs behaviour and integrity.
With PH and Riverford and HNWI as chosen Partners all may go well according to plan. Private investors used to be like a safe harbour with shares well locked. Not a single share would have been sold. Remember old times? Temporarily, dilution is approx 36% as is the addition of voting rights.
Rightly Sareum delivers a hint. Looking forward to hear about any news...
RNS:
Following Admission, the total number of Ordinary Shares in issue will be 95,678,309 and the total number of voting rights will therefore be 95,678,309, and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
Again just my 2cents who cares :)
..It’s what AIM is for..Very cynical that is, isn't it?
PI's have lost a fortune already because of these financing ongoings altogether while SAR cannot await MAD results in a month time, Id say, with a chance to have raised even more on money when results are good.
Do they care at all? Instead they keep progressing 1802! Also and again claiming this molecule will come good, of course.
Any good news never ever will compensate LTH, IMO.
Spot on, Aber, fully agree. IMO, the Bod can claim a bankruptacy anytime when it suits the agenda. All they dinis pull money yet don't really stabilise finances or expenditure.. We don' t even know 3rdP labs that can be a spin off of a big pharma who finally can T/O cheap to serve any warents or debts eventually.
Frankly, I am glad that I have missed the train today. Would it not have been decent to await the results before raising further capital?
Isn't it buying a rabbit in the hat at an remarkable 1/3 discount solely based in anticipation of good MAD results?
Prio No 1 is research and its funding that is for sure.
Many thanks for this little update. Good to hear you enjoyed the trip and gathered.
You all know me meanwhile as a very suspicious person re the BODs agenda and activity. Since the rental lease has not been prolongated according to the late audit report you reinstate my concern that their entertainment may most likely end soon with possibly the results coming out in confirming rather have found a satellite office than a working office in Pampisford.
I wonder how the BOD will manage licencing deals and business in general in the near future with no appropriate infrastructure in place i.e conference room, etc. as it was available over the course of 15-20 years in the past. Up until the trials began.
But time will tell how we are getting on.